HR 3884
118th Congress
House
Health
Blood and blood diseases
Health programs administration and funding
Health promotion and preventive care
Hereditary and development disorders
Medical research
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Introduced: June 7, 2023
See on congress.gov
Everywhere this bill has been
16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 24, 2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 23, 2024
Motion to reconsider laid on the table Agreed to without objection.
Sep 23, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
Sep 23, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
Sep 23, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
Sep 23, 2024
Considered under suspension of the rules. (consideration: CR H5578-5580)
Sep 23, 2024
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Aug 25, 2023
Placed on the Union Calendar, Calendar No. 132.
Aug 25, 2023
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
Jul 19, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
Jul 19, 2023
Committee Consideration and Mark-up Session Held.
Jul 13, 2023
Subcommittee Consideration and Mark-up Session Held
Jul 13, 2023
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 7, 2023
Referred to the House Committee on Energy and Commerce.
Jun 7, 2023
Introduced in House
Plain-English summary
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
3